Skip to main content

Table 1 Elements of information extraction tool on country processes

From: From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

Decision-making on the value of pharmaceuticals

ā€¢ Responsible Institution/Body

ā€¢ Application area (remit)

ā€¢ Evidence assessment

ā€ƒā€ƒāœ  production of evidence report

ā€ƒā€ƒāœ  assessment of evidence report

ā€ƒā€ƒāœ  assessment staff

ā€¢ Evidence appraisal

ā€ƒā€ƒāœ  voting body and members

ā€ƒā€ƒāœ  term of office

ā€¢ Re-Assessment

ā€ƒā€ƒāœ  Regular versus ad hoc

ā€ƒā€ƒāœ  Initiation (who/why)

Decision making on reimbursement and pricing of pharmaceuticals

ā€¢ Responsible Institution / Body

ā€¢ Restrictions